Compound name
Trastuzumab
Compound Image
Trastuzumab.png
Approval Jurisdiction
1998 FDA 2000 EMA
Approved for clinical use
EGFR Breast Cancer
CAS
180288-69-1
Action
EGFR
Approved Drug List
1
Commercial Vendor
Genentech
Reference
Reference 2